Laboratory services and diagnostics company Medtox Scientific has posted a healthy hike in operating profits for the second quarter, despite a challenging operating environment that pegged back sales growth.
Covance has made a major expansion in its US Phase I/IIa drug
development capabilities, buying eight early-phase clinical
development sites from Radiant Research, who now plans to focus on
its Phase II-IV business.